Status:
RECRUITING
Evaluation of the Effectiveness, Safety, and Cost of a Smart Home-based Hospital System for Patients With Interstitial Lung Disease: Prospective Multicenter Randomized Controlled Trial
Lead Sponsor:
Yonsei University
Conditions:
Interstitial Lung Disease
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
This study aims to analyze the effectiveness/safety/cost of the Smart Homespital system that provides a service that allows patients with interstitial lung disease to easily access and use biosignals ...
Eligibility Criteria
Inclusion
- Patients diagnosed with COPD who meet the following pulmonary function test results:
- Pre FEV1 \< 80% \*\*or\*\*
- Pre FVC \< 80% \*\*or\*\*
- DLCO \< 60%
Exclusion
- Patients who do not agree to participate in the study.
- Patients who fail to use the medical device equipment.
- Patients where tracking during the study period is expected to be impossible.
- Patients who have difficulty communicating verbally.
- Patients who are bedridden or unable to exercise at all due to severe cardiorespiratory dysfunction.
- Patients receiving hospital-centered rehabilitation treatment during the study period.
Key Trial Info
Start Date :
September 6 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 2 2026
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT06601790
Start Date
September 6 2024
End Date
May 2 2026
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Pulmonary and Critical Care Medicine
Seoul, South Korea, 03722